Lebenthal Global Advisors’s Cerence CRNC Stock Holding History

Lebenthal Global Advisors’s Portfolio CRNC Stock Details CRNC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-478	Closed	-$48K	–	212
2020 Q4	$48K	Buy	+478	New	+$35.6K	0.03%	259

Other funds holding CRNC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

MCM

Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

VVP

Vulcan Value Partners Birmingham, Alabama $3.77B AUM 9.63% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Lebenthal Global Advisors's CRNC Position: Q1 2021 in Review

Lebenthal Global Advisors sold out of Cerence (CRNC) in Q1 2021, closing a stake of 478 shares — an estimated $48K sold.

Lebenthal Global Advisors first reported a position in CRNC in Q4 2020 and held it in 1 quarter. The position peaked at $48K in Q4 2020. 320 funds tracked by Wall St. Rank hold CRNC as of Q1 2021.

Lebenthal Global Advisors reported no remaining Cerence position as of Q1 2021 after selling out during the quarter.
Lebenthal Global Advisors sold 478 Cerence shares in Q1 2021, an estimated $48K.
Lebenthal Global Advisors first reported a position in Cerence in Q4 2020 and held it in 1 quarter.
Lebenthal Global Advisors's Cerence position peaked at $48K in Q4 2020.
320 funds tracked by Wall St. Rank held Cerence as of Q1 2021.

Based on Lebenthal Global Advisors's 13F filing for Q1 2021, filed 7 May 2021.